Listed

NEUROONE MEDICAL TECHNOLOGIES Corp: Form 10-Q for the period ended Jun 30, 2016

Filed with the SEC on Aug 19, 2016 and accepted by EDGAR at Aug 19, 2016, 17:06 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-06-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2016-04-01 to 2016-06-30$0us-gaap:SalesRevenueNet
Revenue6 months2016-01-01 to 2016-06-30$0us-gaap:SalesRevenueNet
Operating income3 months2016-04-01 to 2016-06-30−$14.1kus-gaap:OperatingIncomeLoss
Operating income6 months2016-01-01 to 2016-06-30−$18.5kus-gaap:OperatingIncomeLoss
Income tax3 months2016-04-01 to 2016-06-30$0us-gaap:IncomeTaxExpenseBenefit
Income tax6 months2016-01-01 to 2016-06-30$0us-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-04-01 to 2016-06-30−$24.7kus-gaap:NetIncomeLoss
Net income6 months2016-01-01 to 2016-06-30−$33.7kus-gaap:NetIncomeLoss
Diluted EPS3 months2016-04-01 to 2016-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS6 months2016-01-01 to 2016-06-30$0.00us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow6 months2016-01-01 to 2016-06-30−$8.2kus-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
Cash and equivalentsAt period end2016-06-30$0us-gaap:Cash
Total assetsAt period end2016-06-30$4.3kus-gaap:Assets
Current liabilitiesAt period end2016-06-30$103.8kus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-06-30$103.8kus-gaap:Liabilities
Shareholders' equityAt period end2016-06-30−$99.5kus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001144204-16-120318. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.